Germany has launched the first compassionate use program for psilocybin in the EU, to treat patients with treatment-resistant depression, allowing licensed clinics to administer psilocybin under medical supervision. The psilocybin will be provided by Filament Health, specifically our botanical formulation, PEX010, and supplied free of charge under this framework.
